Following a series of veterinary clinical trials, Expaniderm was launched at the BSAVA Congress at the beginning of April 2016, and is now commercially available to veterinary surgeons.
Products are shipped directly from our parent company's headquarters in Oxfordshire.
If you have a case that you think would benefit from tissue expansion please get in touch with us via Enquiries and we will be happy to explore how Expaniderm can help.
Expaniderm is the veterinary product for the mother company Oxtex. Oxtex is pioneering novel tissue expander solutions for the primary use in reconstructive and dental surgery. The devices have the potential to replace existing tissue expanders, transform how some plastic surgery is done and open a market for entirely new surgical procedures. Oxtex offers surgeons a superior solution to currently available expanders, namely a self-inflating device whose expansion can be better controlled and whose expansion profile can be tailored to the individual surgical application.
The people behind Expaniderm
David is an experienced entrepreneur with over 25 years experience in early stage technology companies, he has a proven track record of taking early-stage opportunities through to exit. His last company, Site Intelligence Ltd is now a global player in the muti-channel customer analytics software market, supporting blue chip companies world-wide. Before that, he was part of the senior management team that took Oxford Molecular Group, one of the first Isis spin out companies, through to a main market listing in 1994 and becoming COO in 1996. Subsequently, he was the executive Chairman of FWPharma Systems Ltd, a management buyout company in clinical trials management software that was sold to Parexel inc in 2002. He was also a founder of Screen Science Ltd, a multi-media training company sold to the Adval group in 1998. David is also the Non-Executive Chairman of Brain in Hand Ltd, a company providing mobile device applications to help those with impaired executive brain function.
Camilla qualified from The University of Nottingham Veterinary School in 2012 with a first class degree and the highest overall mark in equine veterinary studies. She worked for two years in equine clinical practice before joining Oxtex in September 2014. Camilla is leading the veterinary department of Oxtex. Having run both small animal and equine clinical trials early on, Oxtex have now launched their first veterinary product Expaniderm in 2016. Camilla continues to work with KOLs and other veterinary surgeons to ensure the best development of the veterinary product range.
Professor Debra Archer (BVMS, PhD, CertES (Soft Tissue), Dip.ECVS, FHEA, MRCVS) was appointed as Professor of Equine Surgery at the Philip Leverhulme Equine Hospital, University of Liverpool in 2013; prior to this she had been Senior Lecturer in Equine Soft Tissue Surgery since 2006. Debbie has a wide range of clinical interests including all aspects of equine soft tissue surgery, including laser surgery, and equine trauma/emergency care. Debbie’s research interests include equine clinical epidemiology, laminitis, microbiota work, wound healing, parasitology, vector borne diseases and socioepidemiology. She acted as lead for the Veterinary Clinic Team at the London 2012 Olympic and Paralympic Games. She has recently completed a textbook on equine emergencies and is a regular contributor to veterinary articles in the equine press.
Guillaume Chanoit is a scientific advisor to Oxtex and is the Principal investigator for the international small animal trials. He graduated from the Veterinary School of Toulouse (France) with a doctorate thesis (DEDV) in 1998. Guillaume completed a period of postgraduate training, including an internship and surgical residency (specialty training) in 2003 at the Veterinary School of Lyon (France). He also gained a Master of Sciences in Microsurgery in 2000. Before moving to Bristol in 2011, where he currently is Senior Lecturer in Small Animal Surgery, he has held academic positions in France at the Veterinary School of Lyon (2003-2005) and in the USA at North Carolina State University (2005-2010). He is currently a member of the examination committee of the European College of Veterinary Surgeons and he also on the Editorial Board of the Journal of Small Animal Practice. He lectures on various aspects of Veterinary Surgery across Europe and in the USA.
Come and see us
We will be exhibiting at the following events. Please come and visit us.
- Stand 236 at the BEVA Congress in Liverpool 2017.
- Stand Q60 at London Vet Show Excel arena 2017
- Stand 223 at the ACVS Congress in Indianapolis USA 2017
- Stand 236 at the BSAVA Congress in Birmingham 2018
Exapaniderm has been used in the successful treatment of large and companion animals.
Case studies that include comprehensive image records of before and after treatment are available.
The following abstract posters describing the use of Expaniderm products have been presented by Oxtex at recent events.